Jazz Pharmaceuticals

JAZZNasdaq Ireland Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$15.674 B

$241.46 +0.30%

Close of 21 Sept 2026

Revenue

$4.27B

#749 by revenue

Earnings

-$356.1M

Loss-making

Shares outstanding

64,914,577

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#23United TherapeuticsUTHR$21.1B
#24ViatrisVTRS$19.6B
#25Jazz PharmaceuticalsJAZZ$15.7B
#26Ascendis Pharma A/SASND$15.6B
#27Summit TherapeuticsSMMT$13.5B

What if Jazz Pharmaceuticals were worth as much as…

Open the what-if tool →

Gold $30.3T

$466,367.58

Per share 1,931× higher

Bitcoin $1.72T

$26,493.34

Per share 110× higher

Nvidia $5.48T

$84,416.45

Per share 350× higher

Or at a round number

$20.0B $50.0B $100.0B $200.0B

Where these numbers come from

Share counts and financials for Jazz Pharmaceuticals are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 22 Sept 2026. Read the methodology.